Author

N. Kruglova

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Approach:genetic perturbation / CRISPR· 1 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1 Assay:spatial transcriptomics· 1 Approach:statistical model· 1

Frequent Co-Authors

D. Mazurov· 2 shared A. E. Siniavin· 1 shared A. Filatov· 1 shared A. Maslennikova· 1 shared A. Siniavin· 1 shared A. Vzorov· 1 shared D. Golubev· 1 shared D. Komkov· 1 shared

Activity by Year

2021-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

D. Mazurov

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

SARS-CoV-2 cell-to-cell infection is resistant to neutralizing antibodies

N. Kruglova, A. E. Siniavin, V. A. Gushchin, D. Mazurov

This study quantifies SARS-CoV-2 cell-to-cell infection resistance to neutralizing antibodies, finding it is more than tenfold less susceptible than cell-free infection.

bioRxiv · May 4, 2021Microbiology

Engineering T cell resistance to HIV-1 infection via knock-in of peptides from the heptad repeat 2 domain of gp41

A. Maslennikova, N. Kruglova, S. Kalinichenko, D. Komkov, M. Shepelev, D. Golubev, A. Siniavin, A. Vzorov, A. Filatov, D. Mazurov

This paper develops a CRISPR/Cas9-based method to knock-in HIV-1 inhibitory peptides into T cells, enhancing resistance to HIV-1 infection.

bioRxiv · Apr 30, 2021Microbiology